References and Notes
1
Pellegrino T.
Kudera S.
Liedl T.
Muñoz Javier A.
Manna L.
Parak WJ.
Small
2005,
1:
48
2a
Ingram RS.
Hostetler MJ.
Murray RW.
J. Am. Chem. Soc.
1997,
119:
9175
2b
Hostetler MJ.
Templeton AC.
Murray RW.
Langmuir
1999,
15:
3782
2c
Song Y.
Murray RW.
J. Am. Chem. Soc.
2002,
124:
7096
2d
Song Y.
Huang T.
Murray RW.
J. Am. Chem. Soc.
2003,
125:
11694
2e
Guo R.
Song Y.
Wang GR.
Murray W.
J. Am. Chem. Soc.
2005,
127:
2752
2f
Woehrle GH.
Brown LO.
Hutchinson JE.
J. Am. Chem. Soc.
2005,
127:
2172
3
Weibull B.
Matell M.
Acta Chem. Scand.
1962,
16:
1062
4
Kolomyjec C.
Whelan J.
Bosnich B.
Inorg. Chem.
1983,
22:
2343
5
Muth A.
Asam A.
Huttner G.
Barth A.
Zsolnai L.
Chem. Ber.
1994,
127:
305
6
Doering WE.
Levy LK.
J. Am. Chem. Soc.
1955,
77:
509
7
Feltham RD.
Kasenally A.
Nyholm RS.
J. Organomet. Chem.
1967,
7:
285
8
Keiter RL.
Verkade JG.
Inorg. Chem.
1969,
8:
2115
9
Spectroscopic Data for 2.
1H NMR (500 MHz, CDCl3): δ = 0.85 (t, 3 H, CH3), 1.10-1.40 (m, 18 H, CH2), 3.94 (d, 6 H, CH2O, 3
J(P,H) = 1.9 Hz) ppm. 31P NMR (202 MHz, CDCl3): δ = 93.1 (s) ppm. 13C NMR (126 MHz, CDCl3): δ = 14.0, 22.3, 22.6, 29.2, 30.1, 31.8, 34.5, 34.6, 70.7. IR (ATR): 2923, 2854 (CH2 val.), 1465, 1152, 1037, 954, 855, 730 cm-1. MS (EI): m/z (%) = 274 (24) [M+], 244 (100), 95 (60), 81 (69), 69 (45), 55 (77), 41 (69). Anal. Calcd (%): C, 61.29; H, 9.92. Found: C, 60.81; H, 10.24.
10 CCDC 287796 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
11 Unpublished results.
12
Hughes DL. In Organic Reactions
Vol. 42:
Paquette LA.
J. Wiley and Sons, Inc.;
New York:
1992.
p.335
13
Jones PB.
Parrish NM.
Houston TA.
Stapon A.
Bansal NP.
Dick JD.
Townsend CA.
J. Med. Chem.
2000,
43:
3304
14
Spectroscopic Data for 3a,b and 4a,b.
Compound 3a: 1H NMR (500 MHz, CDCl3): δ = 0.84 (t, 3 H, CH3), 1.10-1.40 (m, 18 H, CH2), 2.30 [s, 9 H, SC(O)CH3], 2.94 [s, 6 H, CH2SC(O)CH3] ppm. 13C NMR (126 MHz, CDCl3): δ = 14.0, 22.6, 23.2, 29.2, 29.5, 29.9, 30.6, 31.8, 35.1, 36.0, 41.0, 194.5 ppm. IR (ATR): 2924, 2853 (CH2 val.), 1744, 1696 [SC(O)R] cm-1. MS (EI): m/z (%) = 420 (0.5) [M+], 377 (30) [M+ - 1 × C(O)CH3], 335 (57) [M+ - 2 × C(O)CH3], 293 (42) [M+ - 3 × C(O)CH3], 43 (100) [C(O)CH3].
Compound 3b: 1H NMR (500 MHz, CDCl3): δ = 1.10-1.30 (m, 12 H, CH2), 1.96 (m, 2 H, =CHCH2), 2.26 [s, 9 H, SC(O)CH3], 2.91 [s, 6 H, CH2SC(O)CH3], 4.86 [dd, 1 H, E, 2
J(H,H) = 1.3 Hz, 3
J(H,H) = 10.0 Hz], 4.92 [dd, 1 H, Z, 2
J(H,H) = 1.9 Hz, 3
J(H,H) = 17.0 Hz), 5.73 (m, 1 H, =CH) ppm. 13C NMR (126 MHz, CDCl3): δ = 23.2, 28.9, 29.1, 29.9, 30.6, 33.7, 35.1, 36.0, 41.0, 114.1, 139.1, 194.6 ppm. IR (ATR): 2980 (=CH val.), 2854, 2826 (CH val.), 1751, 1692 [SC(O)R] cm-1. MS (EI): m/z (%) = 404 (0.5) [M+] 361 (39) [M+ - 1 × C(O)CH3], 319 (66) [M+ - 2 × C(O)CH3], 277 (40) [M+ - 3 × C(O)CH3], 43 (100) [C(O)CH3].
Compound 4a: 1H NMR (500 MHz, CDCl3): δ = 0.86 (t, 3 H, CH3), 1.10-1.40 (m, 21 H, CH2 and SH), 2.55 [d, 6 H, CH2SH, 3
J(H,H) = 8.8 Hz] ppm. 13C NMR (126 MHz, CDCl3): δ = 14.1, 22.6, 23.2, 29.1, 29.3, 30.1, 31.9, 32.4, 41.4 ppm. IR (ATR): 2922, 2852 (CH val.), 2561 (SH val.) cm-1. MS (EI): m/z (%) = 294 (100) [M+].
Compound 4b: 1H NMR (500 MHz, CDCl3): δ = 1.05-1.40 (m, 15 H, CH2 and SH); 1.98-2.08 (m, 2 H, CH2CH=CH2), 2.55 [d, 6 H, CH2SH, 3
J(H,H) = 8.8 Hz], 4.93 [dd, 1 H, E, 2
J(H,H) = 1.3 Hz, 3
J(H,H) = 10.0 Hz], 4.99 [dd, 1 H, Z, 2
J(H,H) = 1.3 Hz, 3
J(H,H) = 17.0 Hz], 5.80 (m, 1 H, =CH) ppm. 13C NMR (126 MHz, CDCl3): δ = 23.2, 28.8, 29.0, 29.3, 30.0, 32.4, 33.7, 41.3, 114.2, 139.1. IR (ATR): 2980 (=CH val.), 2925, 2853 (CH val.), 2568 (SH val.) cm-1. MS (EI): m/z (%) = 278 (53) [M+], 41 (100).